Lucid Diagnostics Inc.
Status: Publicly traded
Direct answer
Lucid Diagnostics Inc. is publicly traded on NASDAQ under the ticker LUCD.
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key...
Can you invest in Lucid Diagnostics Inc.?
Yes. Lucid Diagnostics Inc. trades publicly on NASDAQ as LUCD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Lucid Diagnostics Inc.
Detailed equity research is provided by MarketSnap.